Market Analysis and Insights: Global miRNA Kits Market
Due to the COVID-19 pandemic, the global miRNA Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Synthesis Kits accounting for % of the miRNA Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research & Academic Institutes segment is altered to an % CAGR throughout this forecast period.
China miRNA Kits market size is valued at US$ million in 2021, while the US and Europe miRNA Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe miRNA Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of miRNA Kits include Thermo Fisher Scientific, Agilent, Sigma-Aldrich(Merck), Qiagen, Bio-Rad, Promega, Funakoshi Co., Ltd., BioVendor and Canopy Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global miRNA Kits Scope and Segment
miRNA Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global miRNA Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Synthesis Kits
Isolation Kits
Others
Segment by Application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
Others
By Company
Thermo Fisher Scientific
Agilent
Sigma-Aldrich(Merck)
Qiagen
Bio-Rad
Promega
Funakoshi Co., Ltd.
BioVendor
Canopy Biosciences
Genecopoeia
GenoSensor
Takara Bio
Zymo Research
Biocat
LC Sciences
NanoString Technologies
Quanta BioSciences
Phalanx Biotech
FUJIFILM Wako Pure Chemical Corporation
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Due to the COVID-19 pandemic, the global miRNA Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Synthesis Kits accounting for % of the miRNA Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research & Academic Institutes segment is altered to an % CAGR throughout this forecast period.
China miRNA Kits market size is valued at US$ million in 2021, while the US and Europe miRNA Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe miRNA Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of miRNA Kits include Thermo Fisher Scientific, Agilent, Sigma-Aldrich(Merck), Qiagen, Bio-Rad, Promega, Funakoshi Co., Ltd., BioVendor and Canopy Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global miRNA Kits Scope and Segment
miRNA Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global miRNA Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Synthesis Kits
Isolation Kits
Others
Segment by Application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
Others
By Company
Thermo Fisher Scientific
Agilent
Sigma-Aldrich(Merck)
Qiagen
Bio-Rad
Promega
Funakoshi Co., Ltd.
BioVendor
Canopy Biosciences
Genecopoeia
GenoSensor
Takara Bio
Zymo Research
Biocat
LC Sciences
NanoString Technologies
Quanta BioSciences
Phalanx Biotech
FUJIFILM Wako Pure Chemical Corporation
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
Pre-order Enquiry
Download Free Sample








